Review Article
Pertuzumab: Unprecedented benefit in human epidermal growth factor receptor 2-positive breast cancer
Volume 01 | Issue 2 | July 2015
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Private Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Private Ltd. and was migrated to Scientific Scholar after the change of Publisher.